AsianScientist (Sep. 16, 2016) – Thermo Fisher Scientific has opened a new good manufacturing practices (GMP) standards facility in South Korea. GMP is a requirement for all pharmaceutical facilities.
Located in Seoul, the new site will provide local, regional and global pharmaceutical and biotech companies with clinical supplies, ranging from storage, local labeling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies, to clinical site returns management.
Over the past few years, the number of clinical trials have consistently grown in South Korea. With an increased number of core clinical trial sites certified by the Ministry of Food and Drug Safety, South Korea boasts the second highest number of approved clinical trial sites globally, making it a leading emerging nation for clinical trial research in Asia.
In addition, South Korean pharmaceutical companies have demonstrated a strong passion for innovative drug development, resulting in a robust industry contributing to therapeutic healthcare developments at the local and global level.
———
Source: Thermo Fisher Scientific Inc.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
